Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06400875 · ClinicalTrials.gov registry record
Observational Study to Investigate the Use of Sterilized Porcine Placental Tissue in the Treatment of Chronic VLU
A clinical trial of Wound Heal and Ulcer Venous, sponsored by ConvaTec.
- Active
- Registry status
- 37
- Enrollment target
- 1
- Study location
NCT06400875: Active study of Wound Heal and Ulcer Venous, sponsored by ConvaTec.
NCT06400875 is a study of Wound Heal and Ulcer Venous that is active but no longer recruiting, run by ConvaTec. The registered enrollment target is 37 participants, below the 118-participant average among 23 other Wound Heal trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06400875, a study of Wound Heal and Ulcer Venous, is active but no longer recruiting, sponsored by ConvaTec.
- ACTIVE NOT RECRUITING
- Registry status
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is a multi-center, prospective, clinical trial designed to evaluate the use of InnovaMatrix AC sterilized porcine placental ECM to treat chronic VLUs . The trial will include 30 completed subjects at multiple, experienced clinical centers in the United States.
Primary Outcome
Assessment of ulcer area (percent area reduction from baseline)
Conditions Studied
Interventions
- DEVICE InnovaMatrix® AC Sterilized, Porcine Placental Extracellular Matrix (ECM)
Study Locations (1)
Massachusetts
- The Serena Group - Cambridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2023-07-10 |
| Est. Completion | 2025-12-31 |
What the registry record for NCT06400875 still lists
NCT06400875 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 118-participant average among 23 other Wound Heal trials with a reported enrollment target (69% lower).
The record links to 2 conditions, with Wound Heal appearing as the primary indexed condition, and to 1 intervention - of which InnovaMatrix® AC Sterilized, Porcine Placental Extracellular Matrix (ECM) is the first listed.
NCT06400875 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06400875 about?
NCT06400875 is a clinical study titled "Observational Study to Investigate the Use of Sterilized Porcine Placental Tissue in the Treatment of Chronic VLU". The study is a multi-center, prospective, clinical trial designed to evaluate the use of InnovaMatrix AC sterilized porcine placental ECM to treat chronic VLUs . The trial will include 30 completed subjects at multiple, experienced clinical centers in the United States.
What is the current status of trial NCT06400875?
This trial is currently active not recruiting. The enrollment target is 37 participants. The study started on 2023-07-10. Estimated completion is 2025-12-31.
What conditions does trial NCT06400875 study?
This clinical trial studies the following conditions: Wound Heal, Ulcer Venous.
What interventions are being tested in trial NCT06400875?
The interventions under investigation include: InnovaMatrix® AC Sterilized, Porcine Placental Extracellular Matrix (ECM) (DEVICE).
Who is sponsoring clinical trial NCT06400875?
This trial is sponsored by ConvaTec, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06400875 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound Heal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06400875's enrollment target sits among peer trials
37 18th of 23 higher than 5 of 23 other Wound Heal trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wound Heal trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Tissue Repair Gel in Venous Leg Ulcers in AU/US
RECRUITING · Phase 3
-
Dermabrasion in Mohs: Split-Scar Trial
RECRUITING · NA
-
INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone
RECRUITING · NA
-
EDX110 Randomized Control Trial for Treatment of DFUs
RECRUITING · NA
-
Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI